Tumor topoisomerase II alpha status and response to anthracycline-based neoadjuvant chemotherapy in breast cancer

Hasonló tételek

• One-Year Neoadjuvant Endocrine Therapy in Breast Cancer
  Szerző: Rusz Orsolya, et al.
  Megjelent: (2015)
• Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
  Szerző: Oláh Orsolya, et al.
  Megjelent: (2023)
• Examination of Tumor Regression Grading Systems in Breast Cancer Patients Who Received Neoadjuvant Therapy
  Szerző: Sejben Anita, et al.
  Megjelent: (2020)
• Is Regression after Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer Different in Sentinel and Non-sentinel Nodes?
  Szerző: Cserni Gábor, et al.
  Megjelent: (2018)
• LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas.
  Szerző: Rusz Orsolya, et al.
  Megjelent: (2018)